Literature DB >> 14668736

Critical size of residual adrenal tissue and recovery from impaired early postoperative adrenocortical function after subtotal bilateral adrenalectomy.

Michael Brauckhoff1, Oliver Gimm, Phuong Nguyen Thanh, Annett Bär, Jörg Ukkat, Katrin Brauckhoff, Thomas Bönsch, Henning Dralle.   

Abstract

BACKGROUND: Subtotal bilateral adrenalectomy may preserve adrenocortical function. Little is known about the early postoperative function of the adrenal remnant.
METHOD: In 10 patients with bilateral adrenal tumors (pheochromocytomas, adrenocortical nodular hyperplasia, and adrenal metastases), plasma adrenocorticotropic hormone (ACTH), serum cortisol, and maximal cortisol liberation were examined with an ACTH test after subtotal bilateral adrenalectomy, which left 15% to 30% of adrenal tissue in situ.
RESULTS: In the early postoperative period, all patients had normal basal serum cortisol levels (mean, 415+/-208 nmol/L; normal morning range, 138-690 nmol/L) but pathologically increased plasma ACTH levels (mean, 55+/-42 pmol/mL; normal, <10.1 pmol/L). In 6 patients, a pathologic ACTH test result was observed. During follow-up (mean, 11.3+/-7.6 months), all patients were found to have a normal ACTH test result. None of the patients required steroid supplementation. However, in patients with both familial pheochromocytoma and impaired adrenocortical function during the early postoperative period, the maximal increase of serum cortisol after ACTH stimulation was significantly reduced (mean, 301+/-86.8 nmol/L) compared with control subjects (mean, 490+/-132.6 nmol/L; P=.019).
CONCLUSION: After subtotal bilateral adrenalectomy left 15% to 30% of adrenal tissue in situ, functional recovery could be observed in all patients. However, subclinical impairment of the adrenocortical function with questionable clinical significance has to be considered in some of the patients. Especially during the early postoperative period, careful observation of the patients without exogenous steroid administration is required.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668736     DOI: 10.1016/j.surg.2003.08.005

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  19 in total

Review 1.  Minimal access adrenal surgery.

Authors:  L M Brunt
Journal:  Surg Endosc       Date:  2006-01-25       Impact factor: 4.584

2.  SAGES guidelines for minimally invasive treatment of adrenal pathology.

Authors:  Dimitrios Stefanidis; Melanie Goldfarb; Kent W Kercher; William W Hope; William Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2013-09-10       Impact factor: 4.584

Review 3.  Adrenal-preserving minimally invasive surgery: update on the current status of laparoscopic partial adrenalectomy.

Authors:  Grant I S Disick; Ravi Munver
Journal:  Curr Urol Rep       Date:  2008-01       Impact factor: 3.092

Review 4.  Retroperitoneal adrenalectomy-learning curve, practical tips and tricks, what limits its wider uptake.

Authors:  Pier Francesco Alesina
Journal:  Gland Surg       Date:  2019-07

5.  Organ-sparing procedures in GU cancer: part 1-organ-sparing procedures in renal and adrenal tumors: a systematic review.

Authors:  Raouf Seyam; Mahmoud I Khalil; Mohamed H Kamel; Waleed M Altaweel; Rodney Davis; Nabil K Bissada
Journal:  Int Urol Nephrol       Date:  2019-01-08       Impact factor: 2.370

6.  Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery.

Authors:  Pavel Nockel; Mustapha El Lakis; Apostolos Gaitanidis; Lily Yang; Roxanne Merkel; Dhaval Patel; Naris Nilubol; Tamara Prodanov; Karel Pacak; Electron Kebebew
Journal:  Surgery       Date:  2017-11-07       Impact factor: 3.982

Review 7.  Partial adrenalectomy: underused first line therapy for small adrenal tumors.

Authors:  Deborah R Kaye; Benjamin B Storey; Karel Pacak; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2010-07       Impact factor: 7.450

Review 8.  [Adrenalectomy for preservation of adrenocortical function. Indication and results].

Authors:  M K Walz
Journal:  Chirurg       Date:  2009-02       Impact factor: 0.955

9.  Partial recovery of adrenal function in a patient with autoimmune Addison's disease.

Authors:  L C C J Smans; P M J Zelissen
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

10.  Pheochromocytoma management, outcomes and the role of cortical preservation.

Authors:  Alisha Gupta; Sandeep Agarwala; Nikhil Tandon; M Srinivas; Minu Bajpai; Devendra Kumar Gupta; Arun Kumar Gupta; Chandersekhar Bal; Rakesh Kumar; Veereshwar Bhatnagar
Journal:  Indian J Pediatr       Date:  2013-11-08       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.